• Aimei Health posted net income of USD 45,440 for the quarter ended March 31, 2026, down from USD 184,662 a year earlier.
• Interest income from trust assets fell to USD 107,424 from USD 598,076, while formation and operating costs dropped to USD 61,984 from USD 413,414.
• Cash totaled USD 18,516 outside the trust, with USD 12.28 million held in the Trust Account; working capital deficit stood at about USD 3.5 million.
• It reiterated expectations to close the United Hydrogen business combination in late 2026, pending China securities regulator approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028880), on June 16, 2026, and is solely responsible for the information contained therein.